TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), today announced that the Company has notified the investors in the Company’s December 2009 Series D Convertible Preferred Stock financing that it is exercising its right to call all previously unexercised five-year warrants to purchase shares of the Company’s common stock issued to the investors in connection with the Series D financing (the “Long-Term Warrants”). The Long-Term Warrants give the Series D investors the right to purchase an aggregate of 6,775,611 shares of common stock at an exercise price of $0.142 per share. Assuming the Series D investors exercise all of the Long-Term Warrants, the Company would receive $962,000 of additional capital, $208,000 of which has previously been received by the Company in connection with the exercise of certain Long- Term Warrants.
